Drug profile · INN
dinoprostone
CERVIDIL
dinoprostone (CERVIDIL) is a prostaglandin e2 receptor agonist. Route of administration: vaginal. Current US regulatory status: approved.
Drug details — dinoprostone
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
dinoprostone (CERVIDIL) is a prostaglandin e2 receptor agonist. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostaglandin E2 receptor agonist
Primary target: Prostaglandin E2 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dinoprostone?
dinoprostone (CERVIDIL) is a prostaglandin e2 receptor agonist. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for dinoprostone?
CERVIDIL is a marketed brand name for dinoprostone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dinoprostone?
dinoprostone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.